Sagent Pharmaceuticals focuses on the development and commercialization of injectable pharmaceutical products for cancer, oncology and urology.
Business Model:
Revenue: $297.8M
Employees: 201-500
Sagent was acquired by
Nichi-Iko Pharmaceutical.
The acquisition happend on 2016-07-11.
Details of the transaction were not public
Address: 1901 N Roselle Rd
City: Schaumburg
State: IL
Zip: 60195
Country: US
Sagent Pharmaceuticals focuses on the development and commercialization of injectable pharmaceutical products for cancer, oncology and urology.
Contact Phone:
+18479081600
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/19/2011
Ticker Symbol:
SGNT
IPO Price:
$16/share
Amount Raised:
$92M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2008 | Series A | 1 | $30M |
Vivo Capital Vivo Capital Vivo Capital Vivo Capital |
9/2007 | Series A | 1 | $53M |
Vivo Capital Vivo Capital Vivo Capital Vivo Capital |
4/2011 | IPO | $92M |
|
6/2009 | Series A | 1 | $30M |
Vivo Capital Vivo Capital Vivo Capital Vivo Capital |
4/2010 | Series B | $0 |
Zhejiang Hisun Pharmaceutical Co. Zhejiang Hisun Pharmaceutical Co. Zhejiang Hisun Pharmaceutical Co. Zhejiang Hisun Pharmaceutical Co. |
4/2010 | Series B | 1 | $40M |
Zhejiang Hisun Pharmaceutical Co. Zhejiang Hisun Pharmaceutical Co. |
---|
Announced Date | Name | Price |
---|---|---|
10/2014 | Omega Laboratories |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|